<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Excessively released <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> is neurotoxic </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="6" ids="14321,29987">Glutamate</z:chebi> transporters maintain the extracellular level of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> by uptake into glia or neurons </plain></SENT>
<SENT sid="2" pm="."><plain>We examined the role of GLT-1, a glial <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporter, in brain damage resulting from transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in mice </plain></SENT>
<SENT sid="3" pm="."><plain>Heterozygous gene deletion of GLT-1 significantly augmented <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> resulting from 1 h of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and 24 h reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, this gene deletion significantly increased brain water contents in ischemic hemisphere at 6 h after reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, intraperitoneal injection of dihydrokainate (10 mg/kg), a specific inhibitor of GLT-1, augmented <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These data suggest that GLT-1 limits <z:hpo ids='HP_0002181'>brain edema</z:hpo> resulting from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>